Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | IDH1 | O75874 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SHBG | P04278 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2608675 | 0.91 | CYP3A4 (0.40) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL2612596 | 0.91 | CYP3A4 (0.40) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL13652843 | 0.86 | BCL2 (0.39) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL14513849 | 0.81 | CYP3A4 (0.34) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL9002356 | 0.80 | CYP3A4 (0.45) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL2612597 | 0.80 | SHBG (0.36) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL13652839 | 0.79 | CYP3A4 (0.34) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL200945 | 0.78 | IDH1 (0.53) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL17171809 | 0.77 | CYP3A4 (0.36) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 | |
| SCHEMBL13652840 | 0.77 | CYP3A4 (0.41) | CYP3A4HIF1AIDH1ALDH1A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110589-B2 | Ectoparasiticide composition and a method for exterminating extoparasites | KYOYU AGRI CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20090312378-A1 | ECTOPARASITICIDE COMPOSITION AND A METHOD FOR EXTERMINATING ECTOPARASITES | YASHIMA SANGYO CO., LTD. (JP) | 2009-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312378-A1 | ECTOPARASITICIDE COMPOSITION AND A METHOD FOR EXTERMINATING ECTOPARASITES | EPX, TYR, PPOX | CYP3A4 266/4885HIF1A 2195/4885IDH1 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.